ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985